Lannett Company develops, manufactures and distributes generic prescription pharmaceutical products in tablet, capsule and oral liquid forms to customers throughout the United States. 

Type
Public
HQ
Philadelphia, US
Founded
1942
Size (employees)
1,126 (est)
Lannett Company was founded in 1942 and is headquartered in Philadelphia, US
Report incorrect company information

Lannett Company Office Locations

Lannett Company has offices in Philadelphia, Birmingham, Nashville, Cleveland and in 15 other locations
Philadelphia, US (HQ)
13200 Townsend Road
Show all (19)
Report incorrect company information

Lannett Company Financials and Metrics

Lannett Company Financials

Lannett Company's revenue was reported to be $542.49 m in FY, 2016 which is a 33.3% increase from the previous period.
USD

Revenue (Q2, 2018)

339.3 m

Gross profit (Q2, 2018)

170.8 m

Gross profit margin (Q2, 2018), %

50.3%

Net income (Q2, 2018)

27.3 m

EBIT (Q2, 2018)

87.8 m

Market capitalization (23-Apr-2018)

606.9 m

Cash (31-Dec-2017)

139.9 m

EV

1.4 b
Lannett Company's current market capitalization is $606.9 m.
Annual
USDFY, 2014FY, 2015FY, 2016

Revenue

273.8 m406.8 m542.5 m

Revenue growth, %

49%33%

Cost of goods sold

99.3 m100.5 m237.4 m

Gross profit

174.5 m306.4 m305.1 m
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q2, 2018

Revenue

45.8 m67.3 m80 m93.4 m114.8 m99.4 m106.4 m127.1 m163.7 m161.6 m170.9 m165.7 m339.3 m

Cost of goods sold

24.4 m26.3 m23.9 m21.8 m27.6 m23.7 m28.8 m51.8 m75.3 m70.8 m75.2 m81.6 m168.5 m

Gross profit

21.4 m41 m56.1 m71.6 m87.2 m75.6 m77.6 m75.3 m88.4 m90.7 m95.8 m84.2 m170.8 m

Gross profit Margin, %

47%61%70%77%76%76%73%59%54%56%56%51%50%
Annual
USDFY, 2014FY, 2015FY, 2016

Cash

105.6 m200.3 m224.8 m

Accounts Receivable

61.3 m91.1 m211.7 m

Inventories

44.8 m46.2 m114.9 m

Current Assets

265.5 m370.5 m612.8 m
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q2, 2018

Cash

35.7 m94.4 m84.1 m137.4 m170.6 m208.8 m207.8 m178.8 m225.4 m241.7 m247.3 m132 m139.9 m

Accounts Receivable

29.7 m51.4 m59.2 m75.8 m90.6 m79.7 m107.2 m235 m183.6 m190.5 m223 m215.2 m256.7 m

Inventories

34.5 m35.8 m41.4 m44.1 m42.6 m42.5 m45.2 m124 m116.5 m127.8 m130.2 m123.8 m135.6 m

Current Assets

122.4 m204.4 m237.1 m287.8 m334 m367.2 m400.4 m607 m601.6 m646 m665.6 m554.7 m568.3 m
Annual
USDFY, 2014FY, 2015FY, 2016

Net Income

57.2 m150 m44.9 m

Depreciation and Amortization

6 m5.6 m18.6 m

Inventories

(12 m)1.4 m15.3 m

Accounts Payable

(1.7 m)(2.5 m)(3.7 m)
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q2, 2018

Net Income

(6 m)10.6 m33.6 m35 m79.8 m116 m33.2 m46.7 m41.3 m(29.4 m)(21.2 m)(6.3 m)27.3 m

Depreciation and Amortization

1.6 m3.2 m4.8 m1.3 m2.6 m4 m1.9 m8.1 m20.1 m14.3 m28 m41.6 m27.4 m

Inventories

(2 m)(3.2 m)(8.8 m)774 k2.2 m2.4 m960 k6 m13.3 m(12.8 m)(15.3 m)(8.9 m)(13 m)

Accounts Payable

(6 m)(3.4 m)(1.4 m)(7 m)(1.9 m)(4 m)(1.9 m)(4.9 m)(5.4 m)9.3 m9.1 m11.6 m28.9 m
USDY, 2017

EV/EBIT

15.4 x

EV/CFO

17.8 x

Revenue/Employee

301.3 k

Financial Leverage

2.8 x
Show all financial metrics
Report incorrect company information